Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer’s Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer’s Disease
Authors
Keywords
-
Journal
CNS DRUGS
Volume 32, Issue 6, Pages 579-591
Publisher
Springer Nature
Online
2018-05-07
DOI
10.1007/s40263-018-0515-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
- (2018) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- Stimulation of brain glucose uptake by cannabinoid CB 2 receptors and its therapeutic potential in Alzheimer's disease
- (2016) Attila Köfalvi et al. NEUROPHARMACOLOGY
- Membrane translocation of TRPC6 channels and endothelial migration are regulated by calmodulin and PI3 kinase activation
- (2016) Pinaki Chaudhuri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
- (2015) Eduardo Pérez-Gómez et al. JNCI-Journal of the National Cancer Institute
- Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus
- (2015) Y. Li et al. NEUROSCIENCE
- Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
- (2015) Eduardo Pérez-Gómez et al. JNCI-Journal of the National Cancer Institute
- Is Alzheimer's disease a systemic disease?
- (2014) Jill K. Morris et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Pathways to Alzheimer's disease
- (2014) J. Hardy et al. JOURNAL OF INTERNAL MEDICINE
- Cannabinoid CB2receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
- (2014) Hai-Ying Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amyloid-β and Tau
- (2014) George S. Bloom JAMA Neurology
- Neurogenic effects of β-amyloid in the choroid plexus epithelial cells in Alzheimer’s disease
- (2013) Marta Bolos et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Alzheimer´s Disease and Oxidative Stress: A Review
- (2013) Miroslav Pohanka CURRENT MEDICINAL CHEMISTRY
- Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease
- (2013) Pedro González-Naranjo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency
- (2013) Jiang Wu et al. NEUROBIOLOGY OF AGING
- PGRN haploinsufficiency increased Wnt5a signaling in peripheral cells from frontotemporal lobar degeneration-progranulin mutation carriers
- (2013) Carolina Alquézar et al. NEUROBIOLOGY OF AGING
- Cannabinoid Receptor CB2 Modulates Axon Guidance
- (2013) Gabriel Duff et al. PLoS One
- Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model†
- (2012) Christopher Hyde et al. AGE AND AGEING
- Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson’s disease
- (2012) Lian-Hu Yin et al. BMC NEUROSCIENCE
- The protective effects of tanshinone IIA on β-amyloid protein (1–42)-induced cytotoxicity via activation of the Bcl-xL pathway in neuron
- (2012) Yi-Hua Qian et al. BRAIN RESEARCH BULLETIN
- Peripheral Mitochondrial Dysfunction in Alzheimer’s Disease: Focus on Lymphocytes
- (2012) Kristina Leuner et al. MOLECULAR NEUROBIOLOGY
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors
- (2012) F. S. den Boon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis
- (2010) A. Preet et al. Cancer Prevention Research
- Simvastatin overcomes the resistance to serum withdrawal-induced apoptosis of lymphocytes from Alzheimer’s disease patients
- (2010) Fernando Bartolomé et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
- (2009) Javier Palazuelos et al. BRAIN
- MTDL Design Strategy in the Context of Alzheimers Disease: From Lipocrine to Memoquin and Beyond
- (2009) M. Bolognesi et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabinoid Receptor Type 1- and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling
- (2009) Christine Börner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE ε4, and hyperhomocysteinemia in neurodegenerative dementias
- (2009) Roger M. Lane et al. MEDICAL HYPOTHESES
- Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
- (2009) N. Campillo et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- On the mechanism of inhibition of p27 degradation by 15-deoxy-Δ12,14-prostaglandin J 2 in lymphoblasts of Alzheimer’s disease patients
- (2008) Ú. Muñoz et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Therapeutic potential of CB2 targeting in multiple sclerosis
- (2008) Fabian Docagne et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis
- (2008) Mohammad A. Kamal et al. JOURNAL OF NEURAL TRANSMISSION
- Enhanced proteasome-dependent degradation of the CDK inhibitor p27kip1 in immortalized lymphocytes from Alzheimer's dementia patients
- (2007) Úrsula Muñoz et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now